EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Crocin Supplementation on Clinical Symptoms, Cognitive Function and Psychological Status in Methamphetamine Users: A Randomized Controlled Trial

Morteza Zamani Asadolah-Poor-Kashi, Hamid Reza Banafshe, Mehrdad Simani, Fatemeh Sadat Ghoreishi, Zahra Zanjani, Amir Ghaderi

Jundishapur Journal of Natural Pharmaceutical Products · 31.05.2026 · 21 (2)

DOI: 10.5812/jjnpp-172452 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Jundishapur Journal of Natural Pharmaceutical Products, online erschienen am 31.05.2026. Verfasst von Morteza Zamani Asadolah-Poor-Kashi und 5 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Concurrent methamphetamine (METH) use among patients receiving methadone maintenance treatment (MMT) is a growing clinical concern associated with cognitive impairment, psychological distress, and an increased risk of relapse. Crocin (CRO), a bioactive constituent of saffron (Crocus sativus L.), has antioxidant, anti-inflammatory, and neuroprotective properties.

Objectives

This study aimed to evaluate the effects of CRO supplementation on withdrawal symptoms, craving, sleep quality, cognitive performance, and psychological status in METH users undergoing MMT.

Methods

In this trial, 80 male METH users receiving stable MMT were randomly assigned to CRO (n = 40) or placebo (n = 40) for 8 weeks. All analyses were performed according to the intention-to-treat (ITT) principle and included all 80 randomized participants. The primary outcomes were withdrawal symptoms, assessed with the Amphetamine Withdrawal Questionnaire (AWQ), and craving, measured with the Drug Desire Questionnaire (DDQ). Secondary outcomes were sleep quality (PSQI), sexual function (IIEF), cognitive performance (CAQ), and psychological status (DASS-21).

Results

In the ITT analysis (n = 80), CRO significantly reduced withdrawal symptoms (P = 0.036, η2p=0.091) and craving (P = 0.024, η2p=0.110) compared with placebo. Significant improvements were also observed in sleep quality (P = 0.025, η2p=0.103), anxiety (P < 0.008, η2p=0.157), and depression (P = 0.014, η2p=0.126). No significant effects were observed for sexual function, cognitive performance, or stress (P > 0.05).

Conclusions

The results of this clinical trial indicate that CRO supplementation, administered as a safe and potentially effective adjunct to MMT, may significantly attenuate withdrawal symptoms, reduce craving intensity, improve sleep quality, and alleviate symptoms of anxiety and depression among individuals with METH use disorder. However, the lack of statistically significant improvements in cognitive performance, sexual function, and perceived stress underscores the multifactorial complexity of these clinical domains and highlights the need for further empirical investigation. It is plausible that cognitive deficits resulting from chronic METH exposure, given their putative neurostructural and neurofunctional underpinnings, may require longer treatment durations or integrative therapeutic strategies. Moreover, sexual dysfunction in this patient population is likely mediated by a confluence of physiological, psychological, and psychosocial factors and, as such, may not be readily ameliorated through antioxidant monotherapy alone.

Zitieren

APA

Asadolah-Poor-Kashi, M. Z., Banafshe, H. R., Simani, M., Ghoreishi, F. S., Zanjani, Z., & Ghaderi, A. (2026). Effects of Crocin Supplementation on Clinical Symptoms, Cognitive Function and Psychological Status in Methamphetamine Users: A Randomized Controlled Trial. Jundishapur Journal of Natural Pharmaceutical Products, 21(2). https://doi.org/10.5812/jjnpp-172452

Vancouver

Asadolah-Poor-Kashi MZ, Banafshe HR, Simani M, Ghoreishi FS, Zanjani Z, Ghaderi A. Effects of Crocin Supplementation on Clinical Symptoms, Cognitive Function and Psychological Status in Methamphetamine Users: A Randomized Controlled Trial. Jundishapur Journal of Natural Pharmaceutical Products. 2026;21(2). doi:10.5812/jjnpp-172452

BibTeX
@article{AsadolahPoorKashi2026,
  author = {Asadolah-Poor-Kashi, Morteza Zamani and Banafshe, Hamid Reza and Simani, Mehrdad and Ghoreishi, Fatemeh Sadat and Zanjani, Zahra and Ghaderi, Amir},
  title = {Effects of Crocin Supplementation on Clinical Symptoms, Cognitive Function and Psychological Status in Methamphetamine Users: A Randomized Controlled Trial},
  journal = {Jundishapur Journal of Natural Pharmaceutical Products},
  year = {2026},
  volume = {21},
  number = {2},
  doi = {10.5812/jjnpp-172452}
}
Kostenlos starten →